You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

NEO-CORTEF Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEO-CORTEF?
  • What are the global sales for NEO-CORTEF?
  • What is Average Wholesale Price for NEO-CORTEF?
Summary for NEO-CORTEF
US Patents:0
Applicants:1
NDAs:4
Raw Ingredient (Bulk) Api Vendors: 96
Clinical Trials: 37
DailyMed Link:NEO-CORTEF at DailyMed
Drug patent expirations by year for NEO-CORTEF
Recent Clinical Trials for NEO-CORTEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of North Carolina, Chapel HillPhase 4
University Medical Center GroningenEarly Phase 1
Beth Israel Deaconess Medical CenterPhase 2

See all NEO-CORTEF clinical trials

US Patents and Regulatory Information for NEO-CORTEF

Showing 1 to 7 of 7 entries

Market Dynamics and Financial Trajectory for NEO-CORTEF

Overview of NEO-CORTEF

NEO-CORTEF, also known as hydrocortisone, is a glucocorticoid steroid that is widely used in various medical applications. It is utilized to treat a range of conditions, including skin conditions, hormone disorders, immune system disorders, and allergic reactions[4].

Market Presence and Formulations

NEO-CORTEF is available in multiple formulations, including tablets, creams, ointments, lotions, and rectal enemas. This versatility allows it to be used in different therapeutic areas, such as dermatology, endocrinology, and gastroenterology[1].

Dosage Forms and Strengths

  • Tablets: Available in strengths of 5mg, 10mg, and 20mg.
  • Topical Forms: Creams, ointments, and lotions with varying concentrations.
  • Rectal Forms: Enemas and suppositories.
  • Other Forms: Solutions and suspensions for otic and other uses.

Therapeutic Uses

Hydrocortisone, the active ingredient in NEO-CORTEF, is a glucocorticoid that acts as an agonist to the glucocorticoid receptor. This mechanism allows it to be effective in treating a wide range of conditions, including:

Dermatological Conditions

  • Used to treat corticosteroid-responsive dermatoses such as eczema, psoriasis, and dermatitis[4].

Endocrine Disorders

  • Managed for conditions like adrenal insufficiency and congenital adrenal hyperplasia[4].

Immune and Allergic Conditions

  • Treats immune system disorders and allergic reactions, including acute gouty arthritis and acute otitis externa[4].

Market Dynamics

Demand and Usage

The demand for hydrocortisone-based products like NEO-CORTEF is consistent due to their broad therapeutic applications. These products are prescribed frequently for both acute and chronic conditions, ensuring a steady market demand.

Competition

The market for hydrocortisone products is competitive, with multiple brands and formulations available. Companies such as Pharmacia And Upjohn, Meda Pharms, and Perrigo offer various hydrocortisone-based products, which can impact the market share of NEO-CORTEF[1].

Financial Trajectory

Revenue and Sales

Given the widespread use of hydrocortisone in various medical fields, the revenue generated from NEO-CORTEF and similar products is substantial. However, specific financial data for NEO-CORTEF alone is not readily available. Instead, we can look at the broader context of prescription drug markets.

  • Prescription Drug Market: The overall prescription drug market is growing, driven by increasing healthcare needs and advancements in medical treatments. This growth trend is likely to benefit hydrocortisone-based products[3].

Cost and Pricing

The cost of NEO-CORTEF can vary based on the formulation, strength, and region. Generally, hydrocortisone products are priced competitively due to the presence of multiple manufacturers.

  • Pricing Strategies: Companies often employ competitive pricing strategies to maintain market share. This can include discounts, rebates, and other promotional activities to attract and retain customers[1].

Regulatory Environment

FDA Approval and Compliance

NEO-CORTEF, as a hydrocortisone product, is FDA-approved and must comply with stringent regulatory requirements. This includes adherence to Good Manufacturing Practices (GMP) and periodic inspections to ensure product safety and efficacy[1].

Pediatric and Neonatal Use

While hydrocortisone is used in pediatric and neonatal care, there is a significant gap in FDA-approved drugs for these populations. Initiatives like the Pediatric Trials Consortium aim to improve the availability of data for appropriate use in children, which could impact future formulations and approvals[2].

Market Trends and Future Outlook

Growing Healthcare Needs

The increasing prevalence of chronic diseases and the aging population are driving the demand for effective and safe treatments, including glucocorticoids like hydrocortisone.

Innovations and Developments

Continuous research and development in the pharmaceutical sector may lead to new formulations or combination products that could enhance the market position of NEO-CORTEF or similar hydrocortisone-based products.

Key Takeaways

  • Versatile Therapeutic Applications: NEO-CORTEF is used in various medical fields due to its broad therapeutic efficacy.
  • Competitive Market: The market for hydrocortisone products is competitive, with multiple brands and formulations available.
  • Regulatory Compliance: NEO-CORTEF must adhere to FDA regulations and guidelines.
  • Growing Demand: Increasing healthcare needs and an aging population drive the demand for hydrocortisone-based products.
  • Future Innovations: Ongoing research and development could lead to new formulations and combination products.

FAQs

What is NEO-CORTEF used for?

NEO-CORTEF, or hydrocortisone, is used to treat a variety of conditions including skin conditions, hormone disorders, immune system disorders, and allergic reactions.

What are the different formulations of NEO-CORTEF?

NEO-CORTEF is available in tablets, creams, ointments, lotions, and rectal enemas.

Is NEO-CORTEF FDA-approved?

Yes, NEO-CORTEF is FDA-approved and must comply with FDA regulations.

What are the potential side effects of NEO-CORTEF?

Common side effects include skin thinning, redness, and itching. More severe side effects can include adrenal suppression and increased risk of infections[1].

Can NEO-CORTEF be used in pediatric and neonatal care?

Yes, hydrocortisone can be used in pediatric and neonatal care, but there is a need for more FDA-approved drugs specifically for these populations[2].

Sources

  1. Pharmacompass: Neo-Cortef | Drug Information, Uses, Side Effects, Chemistry
  2. FDA: Second Annual Neonatal Scientific Workshop
  3. Shionogi Inc.: 2Q results - Shionogi Inc.
  4. DrugBank: Hydrocortisone: Uses, Interactions, Mechanism of Action - DrugBank

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.